Ola Caster

1.4k total citations
26 papers, 832 citations indexed

About

Ola Caster is a scholar working on Toxicology, Computational Theory and Mathematics and Statistics and Probability. According to data from OpenAlex, Ola Caster has authored 26 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Toxicology, 9 papers in Computational Theory and Mathematics and 7 papers in Statistics and Probability. Recurrent topics in Ola Caster's work include Pharmacovigilance and Adverse Drug Reactions (16 papers), Computational Drug Discovery Methods (9 papers) and Drug-Induced Adverse Reactions (6 papers). Ola Caster is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (16 papers), Computational Drug Discovery Methods (9 papers) and Drug-Induced Adverse Reactions (6 papers). Ola Caster collaborates with scholars based in Sweden, United Kingdom and United States. Ola Caster's co-authors include G. Niklas Norén, Sarah Watson, Kristina Juhlin, Paula A. Rochon, Hester M. den Ruijter, I. Ralph Edwards, Lucie M. Gattepaille, Birgitta Grundmark, Yasunori Aoki and Andrew Bate and has published in prestigious journals such as Journal of the American Medical Informatics Association, British Journal of Clinical Pharmacology and Drug Safety.

In The Last Decade

Ola Caster

25 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ola Caster Sweden 14 451 159 141 122 119 26 832
Frantz Thiessard France 20 469 1.0× 201 1.3× 245 1.7× 89 0.7× 88 0.7× 60 1.2k
Gianmario Candore Netherlands 9 326 0.7× 100 0.6× 106 0.8× 103 0.8× 89 0.7× 18 515
Elliot G. Brown United Kingdom 5 494 1.1× 202 1.3× 231 1.6× 103 0.8× 185 1.6× 11 1.3k
Louisa Walsh Australia 10 308 0.7× 117 0.7× 103 0.7× 69 0.6× 83 0.7× 30 727
Stella G. Machado United States 10 340 0.8× 182 1.1× 147 1.0× 60 0.5× 99 0.8× 17 969
Charles M. Gerrits United States 14 337 0.7× 130 0.8× 124 0.9× 123 1.0× 64 0.5× 19 1.0k
Vaishali Patadia United States 9 347 0.8× 116 0.7× 92 0.7× 95 0.8× 69 0.6× 13 525
Sue Wood United States 6 326 0.7× 141 0.9× 172 1.2× 58 0.5× 137 1.2× 14 1.1k
Kristina Juhlin Sweden 12 391 0.9× 150 0.9× 134 1.0× 92 0.8× 86 0.7× 17 554
Susan T. Sacks United States 16 501 1.1× 134 0.8× 199 1.4× 97 0.8× 128 1.1× 39 1.8k

Countries citing papers authored by Ola Caster

Since Specialization
Citations

This map shows the geographic impact of Ola Caster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Caster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Caster more than expected).

Fields of papers citing papers by Ola Caster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Caster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Caster. The network helps show where Ola Caster may publish in the future.

Co-authorship network of co-authors of Ola Caster

This figure shows the co-authorship network connecting the top 25 collaborators of Ola Caster. A scholar is included among the top collaborators of Ola Caster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola Caster. Ola Caster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caster, Ola, Yasunori Aoki, Lucie M. Gattepaille, & Birgitta Grundmark. (2020). Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations. Drug Safety. 43(5). 479–487. 116 indexed citations
2.
Ellenius, Johan, Simon Maskell, Tomas Bergvall, et al.. (2019). Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. Drug Safety. 42(12). 1393–1407. 59 indexed citations
3.
Watson, Sarah, Ola Caster, Paula A. Rochon, & Hester M. den Ruijter. (2019). Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 17. 100188–100188. 161 indexed citations
4.
Caster, Ola, Marie‐Laure Kürzinger, Simon Maskell, et al.. (2018). Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. Drug Safety. 41(12). 1355–1369. 43 indexed citations
5.
6.
Chandler, Rebecca E., et al.. (2016). Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. Drug Safety. 40(1). 81–90. 70 indexed citations
7.
Caster, Ola & I. Ralph Edwards. (2015). Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses. BMC Neurology. 15(1). 206–206. 8 indexed citations
8.
Caster, Ola, Kristina Juhlin, Sarah Watson, & G. Niklas Norén. (2014). A Paradigm Shift for Screening Individual Case Reports : Accounting for Quality and Content. Pharmacoepidemiology and Drug Safety. 23. 37–37. 1 indexed citations
9.
Caster, Ola & I. Ralph Edwards. (2014). Comparative Quantitative Benefit-Risk Assessment of High- and Low-Dose Methylprednisolone in Multiple Sclerosis Relapse Management. Pharmacoepidemiology and Drug Safety. 23. 238–238. 1 indexed citations
10.
Norén, G. Niklas, Ola Caster, Kristina Juhlin, & Marie Lindquist. (2014). Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance. Drug Safety. 37(9). 655–659. 31 indexed citations
11.
Caster, Ola, Kristina Juhlin, Sarah Watson, & G. Niklas Norén. (2014). Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank. Drug Safety. 37(8). 617–628. 82 indexed citations
12.
Caster, Ola. (2014). Quantitative methods to support drug benefit-risk assessment. KTH Publication Database DiVA (KTH Royal Institute of Technology). 1 indexed citations
13.
Caster, Ola, G. Niklas Norén, & I. Ralph Edwards. (2014). Computing limits on medicine risks based on collections of individual case reports. Theoretical Biology and Medical Modelling. 11(1). 15–15. 2 indexed citations
14.
Strandell, Johanna, Ola Caster, Johan Hopstadius, I. Ralph Edwards, & G. Niklas Norén. (2013). The Development and Evaluation of Triage Algorithms for Early Discovery of Adverse Drug Interactions. Drug Safety. 36(5). 371–388. 24 indexed citations
15.
Strandell, Johanna, Ola Caster, Andrew Bate, G. Niklas Norén, & I. Ralph Edwards. (2011). Reporting Patterns Indicative of Adverse Drug Interactions. Drug Safety. 34(3). 253–266. 28 indexed citations
16.
Star, Kristina, Ola Caster, Andrew Bate, & I. Ralph Edwards. (2011). Dose Variations Associated with Formulations of NSAID Prescriptions for Children. Drug Safety. 34(4). 307–317. 6 indexed citations
17.
Caster, Ola, G. Niklas Norén, David Madigan, & Andrew Bate. (2010). Large‐scale regression‐based pattern discovery: The example of screening the WHO global drug safety database. Statistical Analysis and Data Mining The ASA Data Science Journal. 3(4). 197–208. 49 indexed citations
18.
Caster, Ola, G. Niklas Norén, David Madigan, & Andrew Bate. (2008). Large-Scale Regression-Based Pattern Discovery in International Adverse Drug Reaction Surveillance. 5 indexed citations
19.
Caster, Ola. (2007). Mining the WHO Drug Safety Database Using Lasso Logistic Regression. KTH Publication Database DiVA (KTH Royal Institute of Technology). 4 indexed citations
20.
Ribbing, Jakob, Joakim Nyberg, Ola Caster, & E. Niclas Jonsson. (2007). The lasso—a novel method for predictive covariate model building in nonlinear mixed effects models. Journal of Pharmacokinetics and Pharmacodynamics. 34(4). 485–517. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frantz Thiessard Breakdown of academic impact, for papers by Gianmario Candore Breakdown of academic impact, for papers by Elliot G. Brown Breakdown of academic impact, for papers by Louisa Walsh Breakdown of academic impact, for papers by Stella G. Machado Breakdown of academic impact, for papers by Charles M. Gerrits Breakdown of academic impact, for papers by Vaishali Patadia Breakdown of academic impact, for papers by Sue Wood Breakdown of academic impact, for papers by Kristina Juhlin Breakdown of academic impact, for papers by Susan T. Sacks
Rankless by CCL
2026